| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,495 | 4,640 | 17:28 | |
| 4,545 | 4,580 | 17:28 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Median Technologies Achieves ISO 13485:2016 Certification for eyonis Medical Device Quality Management System | 226 | Business Wire | Certification of a robust and compliant Quality Management System for AI-based Software as Medical Devices, as per internationally recognized medical device regulatory standards
Pledge... ► Artikel lesen | |
| 13.03. | Median Technologies Meets the Eligibility Conditions for the PEA-PME Scheme | 281 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as... ► Artikel lesen | |
| 09.03. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28, 2026 | 235 | Business Wire | Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 02.03. | Median Technologies to Showcase eyonis LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Congress of Radiology | 336 | Business Wire | eyonis LCS commercial launch is ongoing in U.S. following FDA 510(k) clearance
CE-marking regulatory process is on-going with a decision expected in Q2 2026 that could trigger commercial... ► Artikel lesen | |
| 27.02. | Median Technologies to present at the TD Cowen 46th Annual Health Care Conference | 334 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for... ► Artikel lesen | |
| 23.02. | Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis LCS | 251 | Business Wire | Webcasts on February 26, 2026, at 5:45 pm CET (held in French): sign-up link and 6:45 pm CET/12:45 pm ET (held in English): sign-up link
Regulatory News:
Median Technologies (FR0011049824, ALMDT... ► Artikel lesen | |
| 18.02. | Median Technologies: FDA Clearance Sets Stage for U.S. Commercialization of eyonis LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc. | 498 | Business Wire | Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis LCS
Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway... ► Artikel lesen | |
| 12.02. | Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis LCS Software as a Medical Device in the United States | 400 | Business Wire | The collaboration follows FDA 510(k) clearance for eyonis LCS and aims to integrate high-performance lung cancer screening detection and diagnosis device into the clinical workflow through the Tempus... ► Artikel lesen | |
| MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 11.02. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31, 2026 | 340 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 09.02. | Median Technologies receives FDA clearance for lung cancer AI tool | 8 | Investing.com | ||
| 09.02. | Median Technologies Receives FDA 510(k) Clearance for eyonis LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening | 580 | Business Wire | eyonis LCS aims to redefine lung cancer screening by supporting diagnosis at early, curable stages, while reducing false positives to avoid unnecessary follow-up procedures, and has the potential... ► Artikel lesen | |
| 19.01. | Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026 | 343 | Business Wire | Record iCRO bookings in 2025; order backlog at an all-time high of €76.6 million despite negative forex impact of (6.5) million
2025 revenue of €23.5 million, up 2.6% vs 2024 despite negative... ► Artikel lesen | |
| 14.01. | Median Technologies: H1 2026 Financial Communication Calendar | 347 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software... ► Artikel lesen | |
| 07.01. | Half Year Median Technologies Liquidity Contract Statement | 618 | Business Wire | Regulatory News:
Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were... ► Artikel lesen | |
| 05.01. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31, 2025 | 275 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 08.12.25 | Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis LCS to Patients Across the U.S. and Europe | 357 | Business Wire | Non-exclusive commercial agreement for the distribution of eyonis LCS in the United States and Europe
The agreement will become effective upon FDA 510(k) clearance
Partner's robust... ► Artikel lesen | |
| 03.12.25 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30, 2025 | 351 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
| 25.11.25 | Median Technologies to Showcase AI-Powered Software as a Medical Device eyonis LCS for Lung Cancer Screening at the RSNA 2025 Annual Meeting | 466 | Business Wire | Peer-reviewed scientific presentation: "Rethinking Lung Cancer Screening: Longitudinal AI/ML Diagnostics beyond Nodule Size Growth"
AI Theater Presentation: "eyonis LCS: Transforming Lung... ► Artikel lesen | |
| 13.11.25 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31, 2025 | 352 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 03.11.25 | Lion Point Capital founder joins Median Technologies board | 3 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALANTIR TECHNOLOGIES | 133,04 | -0,21 % | Palantir: Karp spricht Klartext über Krieg und KI | Künstliche Intelligenz verändert nicht nur Unternehmen - sondern auch Kriege. Palantir-Chef Alex Karp hat das bei der hauseigenen KI-Konferenz AIPCon ungewöhnlich offen formuliert. Die Technologie verschiebe... ► Artikel lesen | |
| ORACLE | 131,42 | -2,22 % | Jetzt geht es um die kritische Infrastruktur - Power Metallic Mines liefert Traumergebnisse, SAP und Oracle testen den Rebound | Täglich prasseln eine Vielzahl von News auf die Kapitalmärkte ein. Dabei liegt ein Schwerpunkt auf internationalen Krisen, welche wiederum hohe Implikationen auf die Ökonomien der Staaten haben. So... ► Artikel lesen | |
| SHOPIFY | 102,86 | -2,72 % | Riskified lanciert Streitbeilegung für Shopify, damit Händler Rückbuchungen automatisch verwalten und entgangene Gewinne zurückgewinnen können | Neues spezialisiertes Angebot erweitert die End-to-End-Risikoinformationsplattform von Riskified auf Shopify-Marken, um die gesamte Kundenerfahrung zu schützen, von der Anmeldung über die Bezahlung... ► Artikel lesen | |
| CROWDSTRIKE | 357,00 | -3,40 % | Opening Bell: Nvidia, Meta, Apple, PSA/NSA, Eli Lilly, Alphabet/CrowdStrike/Steel Dynamics | Die US-Börsen sind mit Gewinnen in die neue Woche gestartet. Der Dow Jones legte 0,83 Prozent zu, der Nasdaq Composite stieg 1,22 Prozent. Im Fokus bleibt weiterhin der Iran-Krieg, dessen Ende nicht... ► Artikel lesen | |
| D-WAVE QUANTUM | 13,700 | -2,00 % | Quantencomputing im Aufwind - profitieren D-Wave und SuperQ? | ||
| ATOSS SOFTWARE | 79,80 | -2,68 % | BERENBERG stuft ATOSS SOFTWARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Atoss Software auf "Buy" mit einem Kursziel von 150 Euro belassen. Zahlreiche Gespräche mit Investoren in den vergangenen Wochen hätten gezeigt... ► Artikel lesen | |
| ZOOM COMMUNICATIONS | 66,35 | +0,32 % | Cathie Wood's once upon a time $1,500 Zoom call by 2026 meets reality as software struggles | ||
| VEEVA SYSTEMS | 159,75 | -0,28 % | Is Veeva Systems a Multimillionaire-Maker Stock? | ||
| BRAINCHIP | 0,083 | -0,36 % | Sell alert! Why this expert is calling time on Nuix and Brainchip shares | ||
| GEN DIGITAL | 17,700 | -0,56 % | Cybersecurity-Aktie Gen Digital auf neuem Jahrestief | ||
| VERSES AI | 0,715 | +2,00 % | Verses AI Inc (3): Verses AI closes $745,805 private placement | ||
| GRAB | 3,158 | -0,44 % | Southeast Asia's "super app" Grab earns revenue $3.37B in 2025, Malaysia remains biggest market | ||
| SENTINELONE | 12,550 | 0,00 % | SentinelOne, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| TREND MICRO | 29,200 | -1,82 % | Analyse von Trend Micro: KI-Sicherheitslücken nehmen zu und werden kritischer | ||
| MITEK SYSTEMS | 12,500 | +1,30 % | Mitek Systems: Mitek Strengthens Its Unassisted Video Verification Solution for the Spanish Market as AI-Driven Identity Fraud Accelerates | SEPBLAC-compliant digital onboarding helps regulated entities stay ahead of deepfakes and digital manipulation without adding friction
Mitek Systems (NASDAQ: MITK), a global leader in digital identity... ► Artikel lesen |